{
    "Symbol": "ICLR",
    "AssetType": "Common Stock",
    "Name": "ICON PLC",
    "Description": "ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe, the United States and internationally. The company is headquartered in Dublin, Ireland.",
    "CIK": "1060955",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH",
    "Address": "SOUTH COUNTY BUSINESS PARK, LEOPARDSTOWN, DUBLIN 18, IE",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "27093451000",
    "EBITDA": "1719507000",
    "PERatio": "38.04",
    "PEGRatio": "1.169",
    "BookValue": "115.74",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "8.6",
    "RevenuePerShareTTM": "101.01",
    "ProfitMargin": "0.0858",
    "OperatingMarginTTM": "0.133",
    "ReturnOnAssetsTTM": "0.0413",
    "ReturnOnEquityTTM": "0.0777",
    "RevenueTTM": "8331892000",
    "GrossProfitTTM": "2218741000",
    "DilutedEPSTTM": "8.6",
    "QuarterlyEarningsGrowthYOY": "0.257",
    "QuarterlyRevenueGrowthYOY": "0.049",
    "AnalystTargetPrice": "367.2",
    "AnalystRatingStrongBuy": "6",
    "AnalystRatingBuy": "10",
    "AnalystRatingHold": "2",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "38.04",
    "ForwardPE": "20.58",
    "PriceToSalesRatioTTM": "3.109",
    "PriceToBookRatio": "2.734",
    "EVToRevenue": "3.55",
    "EVToEBITDA": "18.94",
    "Beta": "1.226",
    "52WeekHigh": "347.72",
    "52WeekLow": "221.19",
    "50DayMovingAverage": "322.96",
    "200DayMovingAverage": "295.77",
    "SharesOutstanding": "82817000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}